Skip to main content
OpenTrials

Clinical trial condition

Refractory/Relapsed Acute Myeloid Leukaemia

Explore clinical trials studying Refractory/Relapsed Acute Myeloid Leukaemia. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Refractory/Relapsed Acute Myeloid Leukaemia trial results

Recruiting

Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia

NCT06326021

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
  • BeijingGoBroadH Beijing, China
View Trial Details

Related conditions